SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-023593
Filing Date
2018-09-26
Accepted
2018-09-26 16:02:18
Documents
5
Period of Report
2018-09-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20180924.htm 8-K 33870
2 EX-99.1 sndx-ex991_7.htm EX-99.1 15001
3 EX-99.2 sndx-ex992_6.htm EX-99.2 25452
4 GRAPHIC gkyhorqz2ih5000001.jpg GRAPHIC 118052
5 GRAPHIC g05dugzwwwyy000001.jpg GRAPHIC 118052
  Complete submission text file 0001564590-18-023593.txt   398685
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 181087979
SIC: 2834 Pharmaceutical Preparations